Daily Derm Times: August 12, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

It’s Time to Treat Moderate Psoriasis Seriously

Explore the evolving landscape of moderate psoriasis treatment, emphasizing patient-centered care and innovative therapies for improved quality of life.

Low BSA Psoriasis Can Carry High Disease Burden

New insights reveal that those with low BSA involvement often face significant disease burdens, challenging traditional treatment criteria.

Guselkumab Improves QoL in Plaque Psoriasis Patients, According to Long-Term G-EPOSS Study Results

New 76-week data reveals guselkumab's significant benefits for plaque psoriasis, enhancing clinical outcomes, improving quality of life, and reducing stigmatization.

HS Summit Spotlights Gaps in Diagnosis and Care

Steven Daveluy, MD, highlighted lack of awareness and early misdiagnosis as major barriers to effective HS care.

Understanding the Topical Treatment Path for Pediatric Atopic Dermatitis

Tina Bhutani, MD, MAS, highlights emerging topical treatments for pediatric atopic dermatitis, emphasizing improved adherence in younger children, the potential impact of ruxolitinib FDA approval for ages 2 and up, and the promise of ongoing trials in infants under 2 years.